Aandelen in “Farmaceutica”

Aandeel Datum Koers Evolutie
vlag Nanobiotix 11/08 38,720 USD
+7,02% 		+7,02%
vlag Nanobiotix 12/08 34,520 EUR
+3,42% 		+3,42%
vlag Nektar Therapeutics 11/08 75,500 USD
+0,85% 		+0,85%
vlag NervGen Pharma Corp 11/08 1,740 USD
+2,35% 		+2,35%
vlag Novartis AG 12/08 124,200 CHF
-1,32% 		-1,32%
vlag Novartis AG 11/08 154,610 USD
-1,39% 		-1,39%
vlag Novo Nordisk A/S 11/08 47,170 USD
-1,17% 		-1,17%
vlag Novo Nordisk A/S 12/08 40,005 EUR
-2,19% 		-2,19%
vlag Nurix Therapeutics Inc 11/08 25,960 USD
+0,31% 		+0,31%

Nieuws over “Farmaceutica”

14:00 · Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri · Persbericht

14:00 · Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri · Persbericht

11:30 · Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market · Persbericht

11/08 · Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices · Persbericht

11/08 · AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD) · Persbericht

11/08 · Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update · Persbericht

11/08 · Zymeworks Announces Participation in Upcoming Investor Conferences · Persbericht

10/08 · Immunic Appoints Elena Ridloff to Board of Directors · Persbericht

10/08 · Farmaceutische giganten investeren 500 miljard dollar in Amerikaanse productie · Business AM

Key takeaways Internationale farmaceutische giganten investeren honderden miljarden dollars om hun bedrijfsactiviteiten in de Verenigde Staten uit te breiden. Dat schrijft Reuters. Door ongeveer 500 miljard dollar (432,7...

10/08 · Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results · Persbericht

10/08 · IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026 · Persbericht

10/08 · Novo Nordisk A/S - share repurchase programme · Persbericht

10/08 · Novo Nordisk and AWS enter strategic partnership to accelerate drug discovery through AI · Persbericht

7/08 · Are UTZ, VEEE, CRNX Obtaining Fair Deals for their Shareholders? · Persbericht

6/08 · ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 · Persbericht

6/08 · Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors · Persbericht

6/08 · Viatris Reports Second-Quarter 2026 Financial Results · Persbericht

6/08 · Bel20 tikt vers record aan · Tijd.be (€)

urde door een zomerse uitschuiver van zwaargewicht UCB iets langer dan in de rest van Europa, maar de Bel20 heeft nu ook zijn record van begin juli verbeterd.

6/08 · Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons · Persbericht

6/08 · Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases · Persbericht

5/08 · Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome · Persbericht

Mijn selecties